A 39-year-old woman with severe uterine adhesions, which developed after miscarriage treatment, underwent stem cell therapy. Following improvement in menstrual flow and endometrial thickness, embryo ...

New Delhi: In a significant breakthrough in reproductive medicine, doctors at a private hospital in New Delhi have reported two successful live births after treating severe Asherman's Syndrome using ...

Doctors in New Delhi have achieved two successful live births by treating severe Asherman's Syndrome with umbilical cord-derived stem cells. The pioneering procedure offers new hope to women suffering ...

Jayashri Kulkarni receives funding from the National Health and Medical Research Council as a Leadership Level 3 Investigator Grant, and has received clinical trials funding from pharmaceutical ...

Background: Perimenopausal syndrome (PMS), characterised by hormonal imbalance resulting from ovarian aging, causes various symptoms that significantly impair quality of life. Current hormone ...

Deaths from both causes are down, but they still eclipse all other causes, according to new statistics. By Nina Agrawal Despite gains in treatment, cardiovascular disease remains the leading cause of ...

New data from a large US population-based cohort study highlighted uterine fibroids as a potential signal of increased long-term risk for atherosclerotic cardiovascular disease, particularly in women ...

Add Yahoo as a preferred source to see more of our stories on Google. “Uterine cancer is a cancer that starts in the uterus, the ‘womb’ or organ where a pregnancy grows,” says Vincent Wagner, MD, ...

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer announced today the start of its Phase III study SUNFLOWER, an investigational study evaluating the efficacy and safety of 52mg levonorgestrel-releasing ...

Bayer announced today the start of its Phase III study SUNFLOWER, an investigational study evaluating the efficacy and safety of 52mg levonorgestrel-releasing intrauterine system Mirena® for the ...